Back to Startups

LTZ Therapeutics

Bioscience & Disease Healthcare Systems
Bioscience & Disease Healthcare Systems Show less
Bioscience & Disease Healthcare Systems
Bioscience & Disease Healthcare Systems Show less
Website LinkedIn Beijing , Beijing , China
About LTZ Therapeutics

LTZ Therapeutics is an immunotherapy-focused global biotech startup dedicated to developing myeloid engagers for clinical trials, particularly in the fields of oncology and autoimmune diseases.

Business Information
Target Customers
healthcare providers research institutions pharmaceutical companies
Industry Categories
Bioscience & Disease Healthcare Systems
Business Model
Revenue Model Biotech licensing and partnerships
Pricing Strategy Not applicable (clinical trials)
Sales Channels direct partnerships, collaborations with research institutions
Funding Timeline
Round Date Amount Investors
Series A Apr 24, 2025 $40.0M Unknown
Founders

No founder information available.

Investors

No investor information available.

Recent Mentions
chuminhua432
Minhua Chu @chuminhua432
Apr 24, 2025

🇨🇳 bio #LTZ Therapeutics announced the oversubscription and successful completion of its Series A+ #financing round, raising a total of $40 million. The newly raised funds will primarily support the Ph1 clinical trial of its lead candidate, LTZ-301 — a FIC myeloid engager https://t.co/1b2qM03BUi

View on Twitter
Similar Startups
BioTroy Therapeutics
87% match

BioTroy Therapeutics is a biotechnology company focused on developing innovative anti-tumor therapeu...
Tcelltech
87% match

Tcelltech is a clinical-stage biopharma focused on developing immunotherapies.
Illimis Therapeutics
87% match

Illimis Therapeutics is a biotechnology company focused on developing innovative therapies to addres...
Avammune Therapeutics
86% match

Avammune Therapeutics is a biopharmaceutical company focused on small molecule drug discovery and de...